Thyrogen: profile and news

Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
Sales of Thyrogen(R) (thyrotropin alfa for injection) increased 30 percent to $23 million in the first quarter, up from $17.7 million a year earlier. ... - MSN Money

Zacks Bull and Bear of the Day Highlights: Linear Technology ...  Apr 24, 2006
We are optimistic about the strong growth of its key products particularly that of Thyrogen and Synvisc. Launch of Myozyme in 2006 will further support growth. ... - Black Enterprise,